226 related articles for article (PubMed ID: 32073142)
61. Increased expression of activation markers in renal cell carcinoma infiltrating lymphocytes.
Shabtai M; Ye H; Frischer Z; Martin J; Waltzer WC; Malinowski K
J Urol; 2002 Nov; 168(5):2216-9. PubMed ID: 12394762
[TBL] [Abstract][Full Text] [Related]
62. Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma.
Tripathi A; Lin E; Xie W; Flaifel A; Steinharter JA; Stern Gatof EN; Bouchard G; Fleischer JH; Martinez-Chanza N; Gray C; Mantia C; Thompson L; Wei XX; Giannakis M; McGregor BA; Choueiri TK; Agarwal N; McDermott DF; Signoretti S; Harshman LC
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33177176
[TBL] [Abstract][Full Text] [Related]
63. DAB2IP Plays Important Clinical Significance and Correlates With Immune Infiltration in Renal Cell Carcinoma.
Cao H; Zhang J; Wang W
Technol Cancer Res Treat; 2020; 19():1533033820936682. PubMed ID: 32583730
[TBL] [Abstract][Full Text] [Related]
64. The correlation between size of renal cell carcinoma and its histopathological characteristics: a single center study of 1867 renal cell carcinoma cases.
Zhang C; Li X; Hao H; Yu W; He Z; Zhou L
BJU Int; 2012 Dec; 110(11 Pt B):E481-5. PubMed ID: 22540142
[TBL] [Abstract][Full Text] [Related]
65. Expression of apoptotic regulatory molecules in renal cell carcinoma: elevated expression of Fas ligand.
Olive C; Cheung C; Nicol D; Falk MC
Immunol Cell Biol; 1999 Feb; 77(1):11-8. PubMed ID: 10101681
[TBL] [Abstract][Full Text] [Related]
66. Using DNA sequencing data to quantify T cell fraction and therapy response.
Bentham R; Litchfield K; Watkins TBK; Lim EL; Rosenthal R; Martínez-Ruiz C; Hiley CT; Bakir MA; Salgado R; Moore DA; Jamal-Hanjani M; ; Swanton C; McGranahan N
Nature; 2021 Sep; 597(7877):555-560. PubMed ID: 34497419
[TBL] [Abstract][Full Text] [Related]
67. The Different T-cell Receptor Repertoires in Breast Cancer Tumors, Draining Lymph Nodes, and Adjacent Tissues.
Wang T; Wang C; Wu J; He C; Zhang W; Liu J; Zhang R; Lv Y; Li Y; Zeng X; Cao H; Zhang X; Xu X; Huang C; Wang L; Liu X
Cancer Immunol Res; 2017 Feb; 5(2):148-156. PubMed ID: 28039161
[TBL] [Abstract][Full Text] [Related]
68. Quantification of T- and B-cell Immune Receptor Distribution Diversity Characterizes Immune Cell Infiltration and Lymphocyte Heterogeneity in Clear Cell Renal Cell Carcinoma.
Ferrall-Fairbanks MC; Chakiryan NH; Chobrutskiy BI; Kim Y; Teer JK; Berglund A; Mulé JJ; Fournier M; Siegel EM; Dhillon J; Falasiri SSA; Arturo JF; Katende EN; Blanck G; Manley BJ; Altrock PM
Cancer Res; 2022 Mar; 82(5):929-942. PubMed ID: 35031572
[TBL] [Abstract][Full Text] [Related]
69. Mapping the immune environment in clear cell renal carcinoma by single-cell genomics.
Borcherding N; Vishwakarma A; Voigt AP; Bellizzi A; Kaplan J; Nepple K; Salem AK; Jenkins RW; Zakharia Y; Zhang W
Commun Biol; 2021 Jan; 4(1):122. PubMed ID: 33504936
[TBL] [Abstract][Full Text] [Related]
70. Development and validation of an immune prognostic classifier for clear cell renal cell carcinoma.
Gu YY; Chen G; Lin P; Cheng JW; Huang ZG; Luo J; Zhai GQ; Wang YL; Yan HB; Li SH
Cancer Biomark; 2020; 27(2):265-275. PubMed ID: 31929144
[TBL] [Abstract][Full Text] [Related]
71. Radiation induces dynamic changes to the T cell repertoire in renal cell carcinoma patients.
Chow J; Hoffend NC; Abrams SI; Schwaab T; Singh AK; Muhitch JB
Proc Natl Acad Sci U S A; 2020 Sep; 117(38):23721-23729. PubMed ID: 32900949
[TBL] [Abstract][Full Text] [Related]
72. Tim-3 expression represents dysfunctional tumor infiltrating T cells in renal cell carcinoma.
Cai C; Xu YF; Wu ZJ; Dong Q; Li MY; Olson JC; Rabinowitz YM; Wang LH; Sun Y
World J Urol; 2016 Apr; 34(4):561-7. PubMed ID: 26253654
[TBL] [Abstract][Full Text] [Related]
73. The prognostic effect of immunoscore in patients with clear cell renal cell carcinoma: preliminary results.
Selvi I; Demirci U; Bozdogan N; Basar H
Int Urol Nephrol; 2020 Jan; 52(1):21-34. PubMed ID: 31541404
[TBL] [Abstract][Full Text] [Related]
74. Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas.
Guerra N; Guillard M; Angevin E; Echchakir H; Escudier B; Moretta A; Chouaib S; Caignard A
Blood; 2000 May; 95(9):2883-9. PubMed ID: 10779435
[TBL] [Abstract][Full Text] [Related]
75. The significant immunological characteristics of peripheral blood neutrophil-to-lymphocyte ratio and Fas ligand expression incidence in nephrectomized tumor in late recurrence from renal cell carcinoma.
Sejima T; Iwamoto H; Morizane S; Hinata N; Yao A; Isoyama T; Saito M; Takenaka A
Urol Oncol; 2013 Oct; 31(7):1343-9. PubMed ID: 22153754
[TBL] [Abstract][Full Text] [Related]
76. Lack of anti-tumour reactivity despite enhanced numbers of circulating natural killer T cells in two patients with metastatic renal cell carcinoma.
Vyth-Dreese FA; Sein J; van de Kasteele W; Dellemijn TA; van den Bogaard C; Nooijen WJ; de Gast GC; Haanen JB; Bex A
Clin Exp Immunol; 2010 Dec; 162(3):447-59. PubMed ID: 20942806
[TBL] [Abstract][Full Text] [Related]
77. Prognostic significance of extensive necrosis in renal cell carcinoma.
Collins J; Epstein JI
Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
[TBL] [Abstract][Full Text] [Related]
78. [Monitoring of anti-tumour cell-mediated response in patients with renal cell carcinoma, disturbance of T cell proliferation].
Lukesová S; Vroblová V; Hlávková D; Kopecký O; Vokurková D; Morávek P; Safránek H; Soucek P
Vnitr Lek; 2008 Feb; 54(2):139-45. PubMed ID: 23687704
[TBL] [Abstract][Full Text] [Related]
79. Exploration of immune-related genes in high and low tumor mutation burden groups of chromophobe renal cell carcinoma.
Li L; Chen X; Hao L; Chen Q; Liu H; Zhou Q
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32662515
[TBL] [Abstract][Full Text] [Related]
80. The prognostic and predictive value of tumor infiltrating Macrophage and Neutrophil in patient with clear cell renal cell carcinoma: Tumor infiltrating lymphocytes in renal cell carcinoma.
Xu W; Jiang X; Guan C; Gu M
Medicine (Baltimore); 2020 Nov; 99(46):e23181. PubMed ID: 33181696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
